nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—GABBR2—head—muscle cancer	0.0178	0.188	CbGeAlD
Baclofen—GABBR2—testis—muscle cancer	0.0172	0.181	CbGeAlD
Baclofen—GABBR1—cardiac atrium—muscle cancer	0.012	0.127	CbGeAlD
Baclofen—Chlorphenesin—PTGS2—muscle cancer	0.0106	0.691	CrCbGaD
Baclofen—GABBR1—tendon—muscle cancer	0.0105	0.11	CbGeAlD
Baclofen—GABBR1—bone marrow—muscle cancer	0.0102	0.107	CbGeAlD
Baclofen—GABBR1—vagina—muscle cancer	0.00973	0.102	CbGeAlD
Baclofen—GABBR1—testis—muscle cancer	0.00868	0.0914	CbGeAlD
Baclofen—SLC22A8—renal system—muscle cancer	0.0053	0.0559	CbGeAlD
Baclofen—Ibuprofen—PTGS2—muscle cancer	0.00475	0.309	CrCbGaD
Baclofen—SLC22A8—head—muscle cancer	0.00355	0.0374	CbGeAlD
Baclofen—Oedema—Vincristine—muscle cancer	0.00216	0.00243	CcSEcCtD
Baclofen—Infection—Vincristine—muscle cancer	0.00215	0.00241	CcSEcCtD
Baclofen—Thrombophlebitis—Doxorubicin—muscle cancer	0.00213	0.0024	CcSEcCtD
Baclofen—Osteoarthritis—Methotrexate—muscle cancer	0.00213	0.0024	CcSEcCtD
Baclofen—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00212	0.00239	CcSEcCtD
Baclofen—Nervous system disorder—Vincristine—muscle cancer	0.00212	0.00238	CcSEcCtD
Baclofen—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00211	0.00238	CcSEcCtD
Baclofen—Decreased appetite—Dactinomycin—muscle cancer	0.0021	0.00236	CcSEcCtD
Baclofen—Dysgeusia—Etoposide—muscle cancer	0.0021	0.00236	CcSEcCtD
Baclofen—Hyperhidrosis—Vincristine—muscle cancer	0.00209	0.00235	CcSEcCtD
Baclofen—Fatigue—Dactinomycin—muscle cancer	0.00209	0.00234	CcSEcCtD
Baclofen—Back pain—Etoposide—muscle cancer	0.00208	0.00233	CcSEcCtD
Baclofen—Pain—Dactinomycin—muscle cancer	0.00207	0.00233	CcSEcCtD
Baclofen—Anorexia—Vincristine—muscle cancer	0.00206	0.00232	CcSEcCtD
Baclofen—Mood swings—Methotrexate—muscle cancer	0.00202	0.00227	CcSEcCtD
Baclofen—Hypotension—Vincristine—muscle cancer	0.00202	0.00227	CcSEcCtD
Baclofen—Ataxia—Methotrexate—muscle cancer	0.00201	0.00226	CcSEcCtD
Baclofen—Feeling abnormal—Dactinomycin—muscle cancer	0.00199	0.00224	CcSEcCtD
Baclofen—Ill-defined disorder—Etoposide—muscle cancer	0.00199	0.00224	CcSEcCtD
Baclofen—Anaemia—Etoposide—muscle cancer	0.00198	0.00223	CcSEcCtD
Baclofen—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00198	0.00222	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00197	0.00221	CcSEcCtD
Baclofen—Insomnia—Vincristine—muscle cancer	0.00196	0.0022	CcSEcCtD
Baclofen—Paraesthesia—Vincristine—muscle cancer	0.00194	0.00218	CcSEcCtD
Baclofen—Malaise—Etoposide—muscle cancer	0.00193	0.00217	CcSEcCtD
Baclofen—Breast disorder—Methotrexate—muscle cancer	0.00193	0.00217	CcSEcCtD
Baclofen—Vertigo—Etoposide—muscle cancer	0.00193	0.00217	CcSEcCtD
Baclofen—Abdominal pain—Dactinomycin—muscle cancer	0.00191	0.00215	CcSEcCtD
Baclofen—Body temperature increased—Dactinomycin—muscle cancer	0.00191	0.00215	CcSEcCtD
Baclofen—Loss of consciousness—Etoposide—muscle cancer	0.00189	0.00212	CcSEcCtD
Baclofen—Lethargy—Doxorubicin—muscle cancer	0.00189	0.00212	CcSEcCtD
Baclofen—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00189	0.00212	CcSEcCtD
Baclofen—Decreased appetite—Vincristine—muscle cancer	0.00188	0.00211	CcSEcCtD
Baclofen—Gastrointestinal disorder—Vincristine—muscle cancer	0.00187	0.0021	CcSEcCtD
Baclofen—Fatigue—Vincristine—muscle cancer	0.00186	0.00209	CcSEcCtD
Baclofen—Convulsion—Etoposide—muscle cancer	0.00186	0.00209	CcSEcCtD
Baclofen—Hypertension—Etoposide—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Pain—Vincristine—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Constipation—Vincristine—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Diplopia—Doxorubicin—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Osteoarthritis—Doxorubicin—muscle cancer	0.00185	0.00208	CcSEcCtD
Baclofen—Chest pain—Etoposide—muscle cancer	0.00183	0.00205	CcSEcCtD
Baclofen—Affect lability—Doxorubicin—muscle cancer	0.00182	0.00204	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00181	0.00204	CcSEcCtD
Baclofen—Discomfort—Etoposide—muscle cancer	0.0018	0.00203	CcSEcCtD
Baclofen—Face oedema—Doxorubicin—muscle cancer	0.00178	0.00201	CcSEcCtD
Baclofen—Gastrointestinal pain—Vincristine—muscle cancer	0.00177	0.00199	CcSEcCtD
Baclofen—Confusional state—Etoposide—muscle cancer	0.00177	0.00198	CcSEcCtD
Baclofen—Mood swings—Doxorubicin—muscle cancer	0.00175	0.00197	CcSEcCtD
Baclofen—Infection—Etoposide—muscle cancer	0.00174	0.00196	CcSEcCtD
Baclofen—Ataxia—Doxorubicin—muscle cancer	0.00174	0.00195	CcSEcCtD
Baclofen—Asthenia—Dactinomycin—muscle cancer	0.00174	0.00195	CcSEcCtD
Baclofen—Dysuria—Methotrexate—muscle cancer	0.00172	0.00194	CcSEcCtD
Baclofen—Dehydration—Doxorubicin—muscle cancer	0.00172	0.00193	CcSEcCtD
Baclofen—Tachycardia—Etoposide—muscle cancer	0.00171	0.00192	CcSEcCtD
Baclofen—Abdominal pain—Vincristine—muscle cancer	0.00171	0.00192	CcSEcCtD
Baclofen—Body temperature increased—Vincristine—muscle cancer	0.00171	0.00192	CcSEcCtD
Baclofen—Skin disorder—Etoposide—muscle cancer	0.0017	0.00191	CcSEcCtD
Baclofen—Erectile dysfunction—Methotrexate—muscle cancer	0.0017	0.00191	CcSEcCtD
Baclofen—Hyperhidrosis—Etoposide—muscle cancer	0.00169	0.0019	CcSEcCtD
Baclofen—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00169	0.0019	CcSEcCtD
Baclofen—Breast disorder—Doxorubicin—muscle cancer	0.00167	0.00188	CcSEcCtD
Baclofen—Anorexia—Etoposide—muscle cancer	0.00167	0.00188	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00166	0.00187	CcSEcCtD
Baclofen—Diarrhoea—Dactinomycin—muscle cancer	0.00166	0.00186	CcSEcCtD
Baclofen—Pneumonia—Methotrexate—muscle cancer	0.00165	0.00186	CcSEcCtD
Baclofen—Drowsiness—Methotrexate—muscle cancer	0.00164	0.00185	CcSEcCtD
Baclofen—Depression—Methotrexate—muscle cancer	0.00164	0.00184	CcSEcCtD
Baclofen—Hypotension—Etoposide—muscle cancer	0.00164	0.00184	CcSEcCtD
Baclofen—Muscular weakness—Doxorubicin—muscle cancer	0.00163	0.00183	CcSEcCtD
Baclofen—Renal failure—Methotrexate—muscle cancer	0.00162	0.00182	CcSEcCtD
Baclofen—Dysphagia—Doxorubicin—muscle cancer	0.0016	0.0018	CcSEcCtD
Baclofen—Influenza—Doxorubicin—muscle cancer	0.0016	0.0018	CcSEcCtD
Baclofen—Sweating—Methotrexate—muscle cancer	0.00158	0.00177	CcSEcCtD
Baclofen—Paraesthesia—Etoposide—muscle cancer	0.00157	0.00177	CcSEcCtD
Baclofen—Haematuria—Methotrexate—muscle cancer	0.00157	0.00176	CcSEcCtD
Baclofen—Dyspnoea—Etoposide—muscle cancer	0.00156	0.00175	CcSEcCtD
Baclofen—Somnolence—Etoposide—muscle cancer	0.00156	0.00175	CcSEcCtD
Baclofen—Hepatobiliary disease—Methotrexate—muscle cancer	0.00156	0.00175	CcSEcCtD
Baclofen—Asthenia—Vincristine—muscle cancer	0.00155	0.00174	CcSEcCtD
Baclofen—Vomiting—Dactinomycin—muscle cancer	0.00154	0.00173	CcSEcCtD
Baclofen—Rash—Dactinomycin—muscle cancer	0.00153	0.00171	CcSEcCtD
Baclofen—Decreased appetite—Etoposide—muscle cancer	0.00152	0.00171	CcSEcCtD
Baclofen—Gastrointestinal disorder—Etoposide—muscle cancer	0.00151	0.0017	CcSEcCtD
Baclofen—Fatigue—Etoposide—muscle cancer	0.00151	0.0017	CcSEcCtD
Baclofen—Constipation—Etoposide—muscle cancer	0.0015	0.00168	CcSEcCtD
Baclofen—Pain—Etoposide—muscle cancer	0.0015	0.00168	CcSEcCtD
Baclofen—Dysuria—Doxorubicin—muscle cancer	0.00149	0.00168	CcSEcCtD
Baclofen—Diarrhoea—Vincristine—muscle cancer	0.00148	0.00166	CcSEcCtD
Baclofen—Pollakiuria—Doxorubicin—muscle cancer	0.00148	0.00166	CcSEcCtD
Baclofen—Urinary tract disorder—Methotrexate—muscle cancer	0.00146	0.00164	CcSEcCtD
Baclofen—Weight increased—Doxorubicin—muscle cancer	0.00145	0.00163	CcSEcCtD
Baclofen—Urethral disorder—Methotrexate—muscle cancer	0.00145	0.00163	CcSEcCtD
Baclofen—Weight decreased—Doxorubicin—muscle cancer	0.00145	0.00162	CcSEcCtD
Baclofen—Feeling abnormal—Etoposide—muscle cancer	0.00144	0.00162	CcSEcCtD
Baclofen—Hyperglycaemia—Doxorubicin—muscle cancer	0.00144	0.00162	CcSEcCtD
Baclofen—Nausea—Dactinomycin—muscle cancer	0.00144	0.00162	CcSEcCtD
Baclofen—Pneumonia—Doxorubicin—muscle cancer	0.00143	0.00161	CcSEcCtD
Baclofen—Gastrointestinal pain—Etoposide—muscle cancer	0.00143	0.00161	CcSEcCtD
Baclofen—Dizziness—Vincristine—muscle cancer	0.00143	0.00161	CcSEcCtD
Baclofen—Drowsiness—Doxorubicin—muscle cancer	0.00142	0.0016	CcSEcCtD
Baclofen—Visual impairment—Methotrexate—muscle cancer	0.00142	0.0016	CcSEcCtD
Baclofen—Renal failure—Doxorubicin—muscle cancer	0.0014	0.00157	CcSEcCtD
Baclofen—Urticaria—Etoposide—muscle cancer	0.00139	0.00156	CcSEcCtD
Baclofen—Abdominal pain—Etoposide—muscle cancer	0.00138	0.00156	CcSEcCtD
Baclofen—Body temperature increased—Etoposide—muscle cancer	0.00138	0.00156	CcSEcCtD
Baclofen—Eye disorder—Methotrexate—muscle cancer	0.00138	0.00155	CcSEcCtD
Baclofen—Tinnitus—Methotrexate—muscle cancer	0.00138	0.00155	CcSEcCtD
Baclofen—Vomiting—Vincristine—muscle cancer	0.00137	0.00154	CcSEcCtD
Baclofen—Cardiac disorder—Methotrexate—muscle cancer	0.00137	0.00154	CcSEcCtD
Baclofen—Sweating—Doxorubicin—muscle cancer	0.00137	0.00153	CcSEcCtD
Baclofen—Rash—Vincristine—muscle cancer	0.00136	0.00153	CcSEcCtD
Baclofen—Dermatitis—Vincristine—muscle cancer	0.00136	0.00153	CcSEcCtD
Baclofen—Haematuria—Doxorubicin—muscle cancer	0.00136	0.00153	CcSEcCtD
Baclofen—Headache—Vincristine—muscle cancer	0.00135	0.00152	CcSEcCtD
Baclofen—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00135	0.00151	CcSEcCtD
Baclofen—Angiopathy—Methotrexate—muscle cancer	0.00134	0.00151	CcSEcCtD
Baclofen—Mediastinal disorder—Methotrexate—muscle cancer	0.00133	0.0015	CcSEcCtD
Baclofen—Chills—Methotrexate—muscle cancer	0.00132	0.00149	CcSEcCtD
Baclofen—Alopecia—Methotrexate—muscle cancer	0.0013	0.00147	CcSEcCtD
Baclofen—Bradycardia—Doxorubicin—muscle cancer	0.0013	0.00146	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—muscle cancer	0.00129	0.00145	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—muscle cancer	0.00129	0.00144	CcSEcCtD
Baclofen—Nausea—Vincristine—muscle cancer	0.00128	0.00144	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—muscle cancer	0.00128	0.00144	CcSEcCtD
Baclofen—Hypoaesthesia—Doxorubicin—muscle cancer	0.00127	0.00143	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—muscle cancer	0.00126	0.00142	CcSEcCtD
Baclofen—Oedema peripheral—Doxorubicin—muscle cancer	0.00126	0.00142	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—muscle cancer	0.00126	0.00141	CcSEcCtD
Baclofen—Asthenia—Etoposide—muscle cancer	0.00126	0.00141	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—muscle cancer	0.00126	0.00141	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—muscle cancer	0.00125	0.00141	CcSEcCtD
Baclofen—Back pain—Methotrexate—muscle cancer	0.00124	0.0014	CcSEcCtD
Baclofen—Pruritus—Etoposide—muscle cancer	0.00124	0.00139	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—muscle cancer	0.00123	0.00138	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—muscle cancer	0.00121	0.00136	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—muscle cancer	0.0012	0.00135	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—muscle cancer	0.00119	0.00134	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—muscle cancer	0.00119	0.00134	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—muscle cancer	0.00119	0.00134	CcSEcCtD
Baclofen—Anaemia—Methotrexate—muscle cancer	0.00119	0.00134	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—muscle cancer	0.00119	0.00133	CcSEcCtD
Baclofen—Flushing—Doxorubicin—muscle cancer	0.00119	0.00133	CcSEcCtD
Baclofen—Angiopathy—Doxorubicin—muscle cancer	0.00116	0.0013	CcSEcCtD
Baclofen—Malaise—Methotrexate—muscle cancer	0.00116	0.0013	CcSEcCtD
Baclofen—Dizziness—Etoposide—muscle cancer	0.00116	0.0013	CcSEcCtD
Baclofen—Vertigo—Methotrexate—muscle cancer	0.00115	0.0013	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—muscle cancer	0.00115	0.0013	CcSEcCtD
Baclofen—Chills—Doxorubicin—muscle cancer	0.00115	0.00129	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—muscle cancer	0.00114	0.00128	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—muscle cancer	0.00113	0.00127	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—muscle cancer	0.00112	0.00126	CcSEcCtD
Baclofen—Convulsion—Methotrexate—muscle cancer	0.00111	0.00125	CcSEcCtD
Baclofen—Vomiting—Etoposide—muscle cancer	0.00111	0.00125	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—muscle cancer	0.00111	0.00125	CcSEcCtD
Baclofen—Rash—Etoposide—muscle cancer	0.0011	0.00124	CcSEcCtD
Baclofen—Dermatitis—Etoposide—muscle cancer	0.0011	0.00124	CcSEcCtD
Baclofen—Headache—Etoposide—muscle cancer	0.0011	0.00123	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—muscle cancer	0.0011	0.00123	CcSEcCtD
Baclofen—Chest pain—Methotrexate—muscle cancer	0.00109	0.00123	CcSEcCtD
Baclofen—Myalgia—Methotrexate—muscle cancer	0.00109	0.00123	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—muscle cancer	0.00109	0.00122	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00109	0.00122	CcSEcCtD
Baclofen—Discomfort—Methotrexate—muscle cancer	0.00108	0.00122	CcSEcCtD
Baclofen—Back pain—Doxorubicin—muscle cancer	0.00108	0.00121	CcSEcCtD
Baclofen—Confusional state—Methotrexate—muscle cancer	0.00106	0.00119	CcSEcCtD
Baclofen—Vision blurred—Doxorubicin—muscle cancer	0.00105	0.00118	CcSEcCtD
Baclofen—Infection—Methotrexate—muscle cancer	0.00104	0.00117	CcSEcCtD
Baclofen—Nausea—Etoposide—muscle cancer	0.00104	0.00117	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—muscle cancer	0.00103	0.00116	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—muscle cancer	0.00103	0.00116	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—muscle cancer	0.00103	0.00116	CcSEcCtD
Baclofen—Agitation—Doxorubicin—muscle cancer	0.00102	0.00115	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—muscle cancer	0.00102	0.00115	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—muscle cancer	0.00101	0.00114	CcSEcCtD
Baclofen—Malaise—Doxorubicin—muscle cancer	0.001	0.00113	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—muscle cancer	0.001	0.00112	CcSEcCtD
Baclofen—Anorexia—Methotrexate—muscle cancer	0.001	0.00112	CcSEcCtD
Baclofen—Syncope—Doxorubicin—muscle cancer	0.000998	0.00112	CcSEcCtD
Baclofen—Palpitations—Doxorubicin—muscle cancer	0.000983	0.00111	CcSEcCtD
Baclofen—Hypotension—Methotrexate—muscle cancer	0.00098	0.0011	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—muscle cancer	0.000978	0.0011	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—muscle cancer	0.000964	0.00108	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—muscle cancer	0.000961	0.00108	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000956	0.00107	CcSEcCtD
Baclofen—Insomnia—Methotrexate—muscle cancer	0.000949	0.00107	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—muscle cancer	0.000947	0.00106	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—muscle cancer	0.000947	0.00106	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—muscle cancer	0.000944	0.00106	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—muscle cancer	0.000942	0.00106	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000941	0.00106	CcSEcCtD
Baclofen—Discomfort—Doxorubicin—muscle cancer	0.000936	0.00105	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—muscle cancer	0.000935	0.00105	CcSEcCtD
Baclofen—Somnolence—Methotrexate—muscle cancer	0.000933	0.00105	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—muscle cancer	0.000927	0.00104	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—muscle cancer	0.000923	0.00104	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—muscle cancer	0.000916	0.00103	CcSEcCtD
Baclofen—Decreased appetite—Methotrexate—muscle cancer	0.000912	0.00102	CcSEcCtD
Baclofen—Oedema—Doxorubicin—muscle cancer	0.000908	0.00102	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000906	0.00102	CcSEcCtD
Baclofen—Fatigue—Methotrexate—muscle cancer	0.000904	0.00102	CcSEcCtD
Baclofen—Infection—Doxorubicin—muscle cancer	0.000902	0.00101	CcSEcCtD
Baclofen—Pain—Methotrexate—muscle cancer	0.000897	0.00101	CcSEcCtD
Baclofen—Shock—Doxorubicin—muscle cancer	0.000894	0.001	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—muscle cancer	0.000891	0.001	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—muscle cancer	0.000886	0.000996	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—muscle cancer	0.000882	0.000992	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—muscle cancer	0.000878	0.000987	CcSEcCtD
Baclofen—Anorexia—Doxorubicin—muscle cancer	0.000866	0.000973	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—muscle cancer	0.000864	0.000972	CcSEcCtD
Baclofen—Gastrointestinal pain—Methotrexate—muscle cancer	0.000858	0.000964	CcSEcCtD
Baclofen—Hypotension—Doxorubicin—muscle cancer	0.000849	0.000954	CcSEcCtD
Baclofen—Urticaria—Methotrexate—muscle cancer	0.000833	0.000937	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—muscle cancer	0.000829	0.000932	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—muscle cancer	0.000829	0.000932	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000828	0.00093	CcSEcCtD
Baclofen—Insomnia—Doxorubicin—muscle cancer	0.000822	0.000923	CcSEcCtD
Baclofen—Paraesthesia—Doxorubicin—muscle cancer	0.000816	0.000917	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—muscle cancer	0.00081	0.00091	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—muscle cancer	0.000807	0.000908	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—muscle cancer	0.0008	0.000899	CcSEcCtD
Baclofen—Decreased appetite—Doxorubicin—muscle cancer	0.00079	0.000887	CcSEcCtD
Baclofen—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000784	0.000881	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—muscle cancer	0.000783	0.00088	CcSEcCtD
Baclofen—Constipation—Doxorubicin—muscle cancer	0.000777	0.000873	CcSEcCtD
Baclofen—Pain—Doxorubicin—muscle cancer	0.000777	0.000873	CcSEcCtD
Baclofen—Asthenia—Methotrexate—muscle cancer	0.000753	0.000846	CcSEcCtD
Baclofen—Feeling abnormal—Doxorubicin—muscle cancer	0.000748	0.000841	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000743	0.000835	CcSEcCtD
Baclofen—Pruritus—Methotrexate—muscle cancer	0.000742	0.000834	CcSEcCtD
Baclofen—Urticaria—Doxorubicin—muscle cancer	0.000722	0.000811	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—muscle cancer	0.000718	0.000807	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—muscle cancer	0.000718	0.000807	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—muscle cancer	0.000718	0.000807	CcSEcCtD
Baclofen—Dizziness—Methotrexate—muscle cancer	0.000694	0.00078	CcSEcCtD
Baclofen—Vomiting—Methotrexate—muscle cancer	0.000667	0.00075	CcSEcCtD
Baclofen—Rash—Methotrexate—muscle cancer	0.000661	0.000743	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—muscle cancer	0.000661	0.000743	CcSEcCtD
Baclofen—Headache—Methotrexate—muscle cancer	0.000657	0.000739	CcSEcCtD
Baclofen—Asthenia—Doxorubicin—muscle cancer	0.000652	0.000732	CcSEcCtD
Baclofen—Pruritus—Doxorubicin—muscle cancer	0.000643	0.000722	CcSEcCtD
Baclofen—Nausea—Methotrexate—muscle cancer	0.000623	0.0007	CcSEcCtD
Baclofen—Diarrhoea—Doxorubicin—muscle cancer	0.000621	0.000699	CcSEcCtD
Baclofen—Dizziness—Doxorubicin—muscle cancer	0.000601	0.000675	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—muscle cancer	0.000577	0.000649	CcSEcCtD
Baclofen—Rash—Doxorubicin—muscle cancer	0.000573	0.000644	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—muscle cancer	0.000572	0.000643	CcSEcCtD
Baclofen—Headache—Doxorubicin—muscle cancer	0.000569	0.00064	CcSEcCtD
Baclofen—Nausea—Doxorubicin—muscle cancer	0.00054	0.000606	CcSEcCtD
